中关村：关于下属公司多多药业盐酸氨溴索注射液获得《药品注册证书》的公告

Core Viewpoint - Zhongguancun announced that its subsidiary, Duoduo Pharmaceutical, has received the drug registration certificate from the National Medical Products Administration for its product, "Ambroxol Hydrochloride Injection," which has passed the drug registration review and approval process [2] Company Summary - Duoduo Pharmaceutical is a subsidiary of Zhongguancun that has successfully developed "Ambroxol Hydrochloride Injection" [2] - The approval from the National Medical Products Administration marks a significant milestone for Duoduo Pharmaceutical in the pharmaceutical industry [2] Industry Summary - The approval of "Ambroxol Hydrochloride Injection" indicates a positive trend in drug development and regulatory approval within the pharmaceutical sector [2] - This development may enhance the competitive positioning of Duoduo Pharmaceutical in the market for respiratory medications [2]